NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
79 hedge funds and large institutions have $90.3M invested in Navidea Biopharmaceuticals Inc. in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+4
Holders Change %
+5.33%
% of All Funds
2.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
32
Reduced
20
Closed
6
Calls
$4.87M
Puts
$1.47M
Net Calls
+$3.4M
Net Calls Change
+$1.64M
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
$8.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.1M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
$8.97M |
| 4 |
PM
Platinum Management
New York
|
$24.8M |
| 5 |
State Street
Boston,
Massachusetts
|
$4.61M |
